Sponsors & Partners
Organizers
sponsor logo
MDPI
A pioneer in scholarly, open access publishing, Multidisciplinary Digital Publishing Institute (MDPI) has supported academic communities since 1996. Based in Basel, Switzerland, MDPI has the mission to foster open scientific exchange in all forms, across all disciplines. Our 538 diverse and open access journals, including 529 peer-reviewed journals and 9 conference journals, are supported by more than 295,000 academic experts who share our mission, values, and commitment to providing high-quality service for our authors. We serve scholars from around the world to ensure the latest research is freely available and all content is distributed under a Creative Commons Attribution License (CC BY). MDPI's portfolio comprises at least 330 journals with impact factors, 70% of which are ranked in the top 2 quartiles of their respective fields. To view the current impact factors for MDPI journals (according to the Journal Citation Reports), please visit the journal list.
sponsor logo
Pharmaceuticals
Pharmaceuticals (ISSN 1424-8247) is an international scientific journal of medicinal chemistry and related drug sciences. Our aim is to publish updated reviews as well as research articles with comprehensive theoretical and experimental details. Short communications are also accepted; therefore, there is no restriction on the maximum length of the papers. The multidisciplinary journal welcomes manuscripts covering a wide range of aspects involved in drug discovery and development. The following topics are considered: Small molecules as drug candidates: drug discovery, drug design, medicinal chemistry, combinatorial chemistry, SAR, structure-property correlations, molecular modeling, pharmacophore, and bioinformatics; Biomolecules, natural products, phages, and cells as therapeutic tools: peptides, aptamers, glycans, antibodies, extracts, bacteriophages, and stem cells; Biological targets and biomarkers: enzymes, receptors, membranes, genes, ion channels, inhibitors, agonists, antagonists, neurons, binding affinity, biofilms, bacteria, viruses, parasites, and protein–protein interactions; Radiopharmaceutical sciences, radiochemistry, (hybrid-)imaging, and nuclear medicine: radiopharmaceuticals, radiotracers, fluorescent dye labeled tracers, contrast agents, PET/CT, PET/MRI RMI, SPECT/CT, and scintigraphy; Pharmacokinetics and pharmacodynamics: pharmaceutical analyses, drug effects, ADME, animal experimentation, and clinical trials; Pharmaceutical preparations and drug delivery: dosage form design, bioconjugates, prodrugs, formulation, metabolites, nanomaterials, nanomedicines, and drug targeting.
Partnering Societies
sponsor logo
Spanish Society of Medicinal Chemistry (SEQT)
The Spanish Society of Medicinal Chemistry (SEQT) is a multidisciplinary, non-profit body created in 1977. It integrates all Professionals, Companies, and Organisations whose activity is related to Spanish Pharmaceutical R+D. The goals of the SEQT are to promote the development of this field through the organization of scientific meetings that will stimulate professional contacts at both national and international levels, and to contribute to the training of advanced graduate students in the field. The SEQT is incorporated within the European Federation for Medicinal Chemistry and Chemical Biology – EFMC, which groups the majority of graduates and professionals working in Pharmaceutical R+D. The SEQT has Honorary Members, Foundation Members, Full Members, and Protective (Members (pharmaceutical companies) that belong to the academic milieu, to the Consejo Superior de Investigaciones Científicas (CSIC, national research centers) and to private companies.
sponsor logo
Life Sciences Switzerland (LS²)
LS² is the largest scientific society connecting researchers in Switzerland, and originally founded by Prof. Eward Weibel as USGEB (Union of Swiss Societies for Experimental Biology) in 1969, the society has more than 50 year history in uniting researchers from various Life Sciences disciplines, facilitating interdisciplinary collaborating, protecting and promoting scientific work and educating the general public. In 2012, USGEB changed its name to LS2 (Life Sciences Switzerland). Since then, the society has expanded by adding more Sections, becoming the largest Life Sciences Society in Switzerland, representing approx. 1000 members. The society runs scientific programs, organizes conferences and workshops, and coordinates initiatives bringing together academic researchers, industry partners, and early-career scientists.
sponsor logo
The Portuguese Society of Nephrology (SPN)
The Portuguese Society of Nephrology (https://www.spnefro.pt/) is a Public Utility institution dedicated to advancing scientific activity in Nephrology for the benefit of public health. The Society creates structures for dialogue and debate among its members to stimulate the growth of the specialty. To achieve this, it organizes courses, conferences, symposiums, congresses, and professional training programs. It also supports research by promoting study grants and scientific awards, fosters exchanges with peer organizations, and provides dedicated services to its members. Acting in an advisory role to the Portuguese Medical Association and the Government, the institution ensures national and international representation while actively studying and sharing key developments of common interest across the nephrology community.
Media partners
sponsor logo
MedTech Outlook
MedTech Outlook is a superlative podium for suppliers to showcase their products and services and healthcare industry professionals to connect with a global audience of decision-makers. Its unique learn-from-peer approach creates an immense impact in the U.S. market, adding a big difference in this continuously evolving medical tech arena.
sponsor logo
TimesOfAI
Times of AI is a comprehensive platform dedicated to the latest advancements in artificial intelligence. It delivers breaking news, expert insights, and in-depth analysis on AI and emerging technologies. With a strong commitment to accuracy and accessibility, it bridges the gap between complex innovations and everyday understanding. From global trends to exclusive interviews and event coverage, Times of AI empowers professionals, innovators, and enthusiasts to stay informed and ahead in a rapidly evolving digital world.
sponsor logo
AIPressRoom
AIPressRoom is an independent, English-language publication covering the AI economy: the companies, the capital behind them and the people building them. It publishes written interviews with founders, CTOs and researchers, records AI funding rounds as they close, and maintains a global calendar of AI conferences and events. Company press releases are carried separately and labelled as such. Editorial content is produced independently of advertisers and partners.
sponsor logo
Bioanalysis Zone
Bioanalysis Zone is an eCommunity providing the latest news, expert interviews, webinars and commentaries from bioanalytical opinion leaders. Bioanalysis Zone also hosts two annual and bi-annual awards; the Bioanalysis Rising Star Award and the Bioanalysis Outstanding Contribution Award. Register for free to access all of our resources and have tailored content delivered straight to your inbox: https://www.bioanalysis-zone.com/register/
sponsor logo
Clocate
Conference Locate (Clocate) is an international online directory helping users discover conferences, exhibitions, seminars, and workshops worldwide. Its searchable platform brings together events across a broad range of fields, including health and medicine, science, technology, business, education, and industry. Users can search by subject, keywords, location, and date to identify events relevant to their professional and academic interests. Website: https://www.clocate.com/
sponsor logo
Pharmaceutics
Pharmaceutics (ISSN 1999-4923) is a peer-reviewed, open access journal on the science and technology of pharmaceutics and biopharmaceutics, published monthly online by MDPI. The journal provides an advanced forum for the science and technology of pharmaceutics and biopharmaceutics. Covered topics include pharmaceutical formulation, process development, drug delivery, pharmacokinetics, biopharmaceutics, pharmacogenetics, and interdisciplinary research involving, but not limited to, engineering, biomedical sciences, and cell biology. Our aim is to encourage scientists to publish their experimental results and theoretical assumptions in as much detail as possible. There is no restriction on the maximum length of the papers. The full experimental details must be provided so that the results can be reproduced.
sponsor logo
Drugs and Drug Candidates
Drugs and Drug Candidates (ISSN 2813-2998) is an international scientific journal covering all critical steps involved in the story of a marketed or potential therapeutic agent. We aim to offer a comprehensive overview of the scientific approaches used in the development of successful drugs and the search for new promising candidates. Chemistry is the main focus of the journal, although other aspects of drug sciences are also addressed. Reviews, research articles, and other formats will be considered, provided they are supported by solid scientific background and appropriate literature references.
sponsor logo
Future Pharmacology
Future Pharmacology (ISSN 2673-9879) is an international, peer-reviewed, open access journal on basic pharmacology, clinical pharmacology, drug discovery, and therapeutics published quarterly online by MDPI. It aims to achieve a better understanding and dissemination of pharmacological sciences. The journal focuses on publishing full research papers, reviews, and communications, but other article types will also be considered. Authors are encouraged to publish their results in as much detail as possible. Future Pharmacology will consider manuscripts within the field of complementary medicine or alternative medicine only if they are focused on pharmacological research. Regarding submissions involving natural products or chemical compounds, please see our Instructions for Authors for the requirements for natural product and chemical compound identification studies. Full experimental details must be provided so that the results can be reproduced.
sponsor logo
Antibiotics
Antibiotics (ISSN 2079-6382) is an open access, peer reviewed journal on all aspects of antibiotics. Antibiotics is a multi-disciplinary journal encompassing the general fields of biochemistry, chemistry, genetics, microbiology and pharmacology. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. Therefore, there is no restriction on the maximum length of the papers.
sponsor logo
Biophysica
Biophysica (ISSN 2673-4125) is an international, peer-reviewed, scientific, open access journal that aims to understand in quantitative terms how biological systems function using methods and techniques borrowed from the physical and chemical sciences and applied mathematics. Our aim is to provide a multidisciplinary forum to communicate, discuss and integrate all the aspects of modern biophysical sciences and engineering in a broad sense.
sponsor logo
Antioxidants
Antioxidants (ISSN 2076-3921), provides an advanced forum for studies related to the science and technology of antioxidants. It publishes research papers, reviews and communications. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the maximum length of the papers. The full experimental details must be provided so that the results can be reproduced. Electronic files and software regarding the full details of the calculation or experimental procedure, if unable to be published in a normal way, can be deposited as supplementary electronic material.
sponsor logo
Compounds
Compounds (ISSN 2673-6918) is an international, peer-reviewed, open-access journal on compounds research. It publishes reviews, original research papers, communications, letters, and short notes. Manuscripts dealing with chemical compounds; the relationship between the structure, the properties, or the functions of all kinds of compounds; as well as chemical theory and applications are welcome. Our aim is to encourage scientists to publish their theoretical and experimental results in as much detail as possible. There is no restriction on the maximum length of the papers. Full experimental and/or methodical details must be provided.
sponsor logo
Current Issues in Molecular Biology
Current Issues in Molecular Biology (CIMB) (ISSN 1467-3045) is a peer-reviewed journal publishing original articles and reviews in all areas of molecular biology. Submitted articles are subject to an Article Processing Charge (APC) and are open access immediately upon publication. All manuscripts undergo a peer-review process.
sponsor logo
Current Oncology
Current Oncology (ISSN 1718-7729) represents a multidisciplinary medium encompassing health care workers in the field of cancer therapy to report upon and to review progress in the management of this disease. Articles published in the journal typically contain information that is relevant directly to clinical oncology practice, and have clear potential for application to the current or future practice of cancer medicine.
sponsor logo
Chemistry
Chemistry is dedicated to the publication and worldwide dissemination of peer-reviewed research articles, communications, and review papers in all areas of contemporary chemistry. Particular emphasis will be given to publications that bridge traditional disciplines within chemistry, between chemistry and neighboring disciplines or provide insights of interest to the broader chemical and scientific community. We particularly welcome state-of-the-art reviews and highlight articles from experts in all areas of chemistry. This journal delivers research and other publications in open access form. Full experimental and computational details must be provided so that the results can be reproduced and evaluated. Both primary reports and reviews highlighting important advances in fundamental areas of chemistry and/or illustrating the central role of chemistry in bridging the physical and life sciences are welcome.
sponsor logo
Biomedicines
Biomedicines (ISSN 2227-9059) is an open access journal devoted to all aspects of research on human health and disease, the discovery and characterization of new therapeutic targets, therapeutic strategies, and research of naturally driven biomedicines, pharmaceuticals, and biopharmaceutical products. Topics include pathogenesis mechanisms of diseases, translational medical research, clinical studies and applications, biomaterial in biomedical research, natural bioactive molecules, biologics, biosimilar, vaccines, gene therapies, cell-based therapies, targeted specific antibodies, recombinant therapeutic proteins, nanobiotechnology-driven products, targeted therapy, bioimaging, biosensors, biomarkers, biosimilars, and nano-biosimilars. We encourage authors to publish their experimental, theoretical, and computational results in as much detail as possible. There is no restriction on the maximum length of papers or the number of electronic multimedia and supplementary files. For all articles, the full experimental details must be provided so that the results can be reproduced. Electronic files regarding the full details of the experimental procedure, if unable to be published in a normal way, can be deposited as Supplementary Materials (including animated pictures, videos, interactive Excel sheets, software executables and others).
sponsor logo
Therapeutics
Therapeutics (ISSN 2813-9909) is an international, peer-reviewed, open access journal on both modern and established traditional therapeutic techniques. Therapeutics aims to publish cutting edge research focused on the prevention and treatment of human disease. Therapeutics publishes reviews, original research, guidelines, communications, etc. We encourage scientists to publish their experimental and theoretical results in as much detail as possible, including results that may be considered “negative”. There is no restriction on the maximum length of the papers. Full experimental details must be provided so that the results can be reproduced.
sponsor logo
Molecules
Molecules is a leading international, peer-reviewed, open access journal of chemistry published semimonthly online by MDPI. The International Society of Nucleosides, Nucleotides & Nucleic Acids (IS3NA), Spanish Society of Medicinal Chemistry (SEQT) and International Society of Heterocyclic Chemistry (ISHC) are affiliated with Molecules and their members receive discounts on the article processing charges.
sponsor logo
Biomolecules
Biomolecules is an international, peer-reviewed, open access journal on structures and functions of bioactive and biogenic substances, molecular mechanisms with biological and medical implications as well as biomaterials and their applications, published monthly online by MDPI.
sponsor logo
Cancers
Cancers is a peer-reviewed, open access journal of oncology published semimonthly online. The North-East German Society for Gynecological Oncology (NOGGO), Irish Association for Cancer Research (IACR), Spanish Association for Cancer Research (ASEICA), Biomedical Research Centre (CIBM), British Neuro-Oncology Society (BNOS) and more are affiliated with Cancers and their members receive a discount on the article processing charges.
ICOPharm2027

Powered by Sciforum
Disclaimer
Terms and ConditionsPrivacy PolicyAccessibility